David Shaw’s Ocugen OCGN Stock Holding History

David Shaw’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-139,025	Closed	-$55.6K	–	4514
2023 Q3	$55.6K	Sell	139,025 -953,244	-87%	-$471K	﹤0.01%	3909
2023 Q2	$593K	Buy	+1,092,269	New	+$700K	﹤0.01%	3354
2022 Q2	–	Sell	-34,306	Closed	-$113K	–	5639
2022 Q1	$113K	Buy	+34,306	New	+$121K	﹤0.01%	4979

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

David Shaw's OCGN Position: Q4 2023 in Review

David Shaw sold out of Ocugen (OCGN) in Q4 2023, closing a stake of 139,025 shares — an estimated $55.6K sold.

David Shaw first reported a position in OCGN in Q1 2022 and held it in 3 quarters. The position peaked at $593K in Q2 2023. 68 funds tracked by Wall St. Rank hold OCGN as of Q4 2023.

David Shaw reported no remaining Ocugen position as of Q4 2023 after selling out during the quarter.
David Shaw sold 139,025 Ocugen shares in Q4 2023, an estimated $55.6K.
David Shaw first reported a position in Ocugen in Q1 2022 and held it in 3 quarters.
David Shaw's Ocugen position peaked at $593K in Q2 2023.
68 funds tracked by Wall St. Rank held Ocugen as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.